Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 7:9:878797.
doi: 10.3389/fmed.2022.878797. eCollection 2022.

Development and Implementation of the AIDA International Registry for Patients With Still's Disease

Antonio Vitale  1 Francesca Della Casa  2 Giuseppe Lopalco  3 Rosa Maria Pereira  4 Piero Ruscitti  5 Roberto Giacomelli  6 Gaafar Ragab  7   8 Francesco La Torre  9 Elena Bartoloni  10 Emanuela Del Giudice  11 Claudia Lomater  12 Giacomo Emmi  13 Marcello Govoni  14 Maria Cristina Maggio  15 Armin Maier  16 Joanna Makowska  17 Benson Ogunjimi  18   19   20   21 Petros P Sfikakis  22 Paolo Sfriso  23 Carla Gaggiano  1 Florenzo Iannone  3 Marília A Dagostin  4 Ilenia Di Cola  5 Luca Navarini  6 Ayman Abdelmonem Ahmed Mahmoud  7 Fabio Cardinale  9 Ilenia Riccucci  10 Maria Pia Paroli  24 Elena Maria Marucco  12 Irene Mattioli  13 Jurgen Sota  1 Anna Abbruzzese  3 Isabele P B Antonelli  4 Paola Cipriani  5 Abdurrahman Tufan  25 Claudia Fabiani  26 Mustafa Mahmoud Ramadan  7 Marco Cattalini  27 Riza Can Kardas  25 Gian Domenico Sebastiani  28 Henrique A Mayrink Giardini  4 José Hernández-Rodríguez  29 Violetta Mastrorilli  9 Ewa Więsik-Szewczyk  30 Micol Frassi  31 Valeria Caggiano  1 Salvatore Telesca  1 Heitor F Giordano  4 Emmanuele Guadalupi  1 Teresa Giani  32 Alessandra Renieri  33   34   35 Sergio Colella  3 Giulia Cataldi  5 Martina Gentile  5 Alessandra Fabbiani  33   34   35 Ibrahim A Al-Maghlouth  36 Bruno Frediani  37 Alberto Balistreri  38 Donato Rigante  39   40 Luca Cantarini  1
Affiliations

Development and Implementation of the AIDA International Registry for Patients With Still's Disease

Antonio Vitale et al. Front Med (Lausanne). .

Abstract

Objective: Aim of this paper is to present the design, construction, and modalities of dissemination of the AutoInflammatory Disease Alliance (AIDA) International Registry for patients with systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), which are the pediatric and adult forms of the same autoinflammatory disorder.

Methods: This Registry is a clinical, physician-driven, population- and electronic-based instrument implemented for the retrospective and prospective collection of real-world data. The collection of data is based on the Research Electronic Data Capture (REDCap) tool and is intended to obtain evidence drawn from routine patients' management. The collection of standardized data is thought to bring knowledge about real-life clinical research and potentially communicate with other existing and future Registries dedicated to Still's disease. Moreover, it has been conceived to be flexible enough to easily change according to future scientific acquisitions.

Results: Starting from June 30th to February 7th, 2022, 110 Centers from 23 Countries in 4 continents have been involved. Fifty-four of these have already obtained the approval from their local Ethics Committees. Currently, the platform counts 290 users (111 Principal Investigators, 175 Site Investigators, 2 Lead Investigators, and 2 data managers). The Registry collects baseline and follow-up data using 4449 fields organized into 14 instruments, including patient's demographics, history, clinical manifestations and symptoms, trigger/risk factors, therapies and healthcare access.

Conclusions: This international Registry for patients with Still's disease will allow a robust clinical research through collection of standardized data, international consultation, dissemination of knowledge, and implementation of observational studies based on wide cohorts of patients followed-up for very long periods. Solid evidence drawn from "real-life" data represents the ultimate goal of this Registry, which has been implemented to significantly improve the overall management of patients with Still's disease. NCT05200715 available at https://clinicaltrials.gov/.

Keywords: autoinflammatory diseases; personalized medicine; precision medicine; rare diseases; research; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Worldwide distribution of the AIDA network in February 2022.

References

    1. Deliverska M. Patient registries for rare diseases. J IMAB Annu Proceeding Sci Pap. (2016) 22:1166–8. 10.5272/jimab.2016222.1166 - DOI
    1. Jansen-van der Weide MC, Gaasterland CMW, Roes KCB, Pontes C, Vives R, Sancho A, et al. Rare disease registries: potential applications towards impact on development of new drug treatments. Orphanet J Rare Dis. (2018) 13:154. 10.1186/s13023-018-0836-0 - DOI - PMC - PubMed
    1. Public Health - European Commission . Rare Diseases. (2016). Available online at: https://ec.europa.eu/health/non_communicable_diseases/rare_diseases_en (accessed December 4, 2021).
    1. Boulanger V, Schlemmer M, Rossov S, Seebald A, Gavin P. Establishing patient registries for rare diseases: rationale and challenges. Pharmaceut Med. (2020) 34:185–90. 10.1007/s40290-020-00332-1 - DOI - PMC - PubMed
    1. Guidance for Industry . Clin Trials. (2011). p. 21. Available online at: https://www.fda.gov/media/116754/download (accessed December 4, 2021).

Associated data